Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy—A case report.
| Publicado en: | Cancer Chemotherapy & Pharmacology Vol. 95; no. 1; pp. 1 - 7 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
10/22/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188797685&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 188797685 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 03445704 NO9 jtl: Cancer Chemotherapy & Pharmacology issn: 03445704 maglogo: N pubinfo: dt: 10/22/2025 vid: 95 iid: 1 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 188797685 10.1007/s00280-025-04818-0 188797685 ppf: 1 ppct: 6 formats: tig: atl: Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy—A case report. aug: au: Hulskotte, Lotte M. G. de Jong, Loek A. W. Huitema, Alwin D. R. Sijm, Joost Desar, Ingrid Smits, Minke van Erp, Nielka P. affil: https://ror.org/05wg1m734 Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands sug: pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|